Fresh analysis reveals that patients who come off blockbuster slimming jabs like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who stop conventional diet and exercise programs.
Published data in a leading medical journal demonstrates that while obese individuals can lose about a fifth of their total mass while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month once they quit.
"Individuals using such drugs need to be aware of the danger of rapid weight regain when the therapy is stopped," warns expert Dr. Susan Jebb.
This pace of recovery means a reversion to original mass in about one and a half years.
Weighing Treatments
The research, which looked at 37 of trials involving thousands of patients, contrasted the outcomes of GLP-1 agonists with older methods.
Scientists point out that individuals who shed pounds through lifestyle changes alone generally experience a less rapid weight regain—perhaps 0.1 kg a month—post-intervention.
Explaining the Rapid Rebound
Nutrition scientists propose the mode of action of the jabs accounts for the amplified regain.
These medications imitate a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 levels several times higher than normal might result in the system to generate a reduced amount of its own natural hormone, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement means appetite is no longer kept in check, making binge eating a significant risk."
A Chronic Disease?
Medical guidelines advise the injections for individuals with obesity-related medical conditions, alongside recommended diet and exercise modifications.
A number of clinicians say that, considering the significant potential of relapse, the therapy is often ongoing.
This perspective is echoed by pharmaceutical companies, who note that the results "emphasize the persistent character of obesity," comparing it to managing conditions like high blood pressure.
User Experiences
People who have stopped the medication describe a sudden resurgence of cravings.
"It was like a trigger flipping and you become ravenous," recalled an individual.
This challenge is worsened if patients have not established sustainable lifestyle or habit changes during therapy.
Growing Adoption
Survey data suggest that millions of people in the UK have used weight-loss jabs in the past year, with demand continuing to grow.
- Adoption is more common among women compared to men.
- The 40s and 50s age group shows the greatest level of interest.
- A large proportion obtain the drugs through private healthcare rather than public health services.
Ultimately, experts caution that while GLP-1 drugs are powerful agents for shedding pounds, they are not a standalone solution and maintained weight loss hinges on combined behavioural support.
